Protein interaction screening identifies SH3RF1 as a new regulator of FAT1 protein levels

Charles E de Bock1,2, Michael R Hughes3, Kimberly Snyder3

  • 1VIB Center for the Biology of Disease, Leuven, Belgium.

FEBS Letters
|January 28, 2017
PubMed

Insights

SH3RF1 E3 ubiquitin-protein ligase negatively regulates FAT1 cadherin levels. Ablating SH3RF1 increases FAT1 protein and cell surface expression, while SH3RF1 overexpression decreases FAT1 levels, clarifying FAT1 regulation.

Area of Science:

  • Cell biology
  • Molecular biology
  • Biochemistry

Background:

  • Mutations and aberrant expression of FAT1 cadherin are linked to developmental disorders and cancers.
  • The precise regulatory mechanisms governing FAT1 and its signaling pathways are not fully elucidated.

Purpose of the Study:

  • To identify novel protein interactors of the FAT1 cytoplasmic tail to better understand its regulation and function.
  • To investigate the role of identified interactors in modulating FAT1 protein levels and cellular localization.

Main Methods:

  • Yeast two-hybrid library screening against the FAT1 cytoplasmic tail juxtamembrane region.
  • RNA interference (siRNA) to ablate SH3RF1 expression.
  • Western blotting to assess protein levels and cell surface expression.

Main Results:

  • The E3 ubiquitin-protein ligase SH3RF1 was identified as a frequent binding partner of the FAT1 cytoplasmic tail.
  • siRNA-mediated knockdown of SH3RF1 resulted in increased cellular FAT1 protein levels.
  • SH3RF1 ablation led to stabilized FAT1 expression at the cell surface.
  • Overexpression of SH3RF1 reduced overall FAT1 protein levels.

Conclusions:

  • SH3RF1 functions as a negative post-translational regulator of FAT1 protein levels.
  • SH3RF1 promotes the degradation or reduces the stability of FAT1.
  • These findings provide new insights into the molecular mechanisms controlling FAT1 cadherin homeostasis.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K